185 related articles for article (PubMed ID: 34906122)
1. Clinicopathological characteristics and survival outcomes in patients with synchronous lung metastases upon initial metastatic breast cancer diagnosis in Han population.
Lin S; Mo H; Li Y; Guan X; Chen Y; Wang Z; Xu B
BMC Cancer; 2021 Dec; 21(1):1330. PubMed ID: 34906122
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors and Survival of Patients With Liver Metastases at Initial Metastatic Breast Cancer Diagnosis in Han Population.
Lin S; Mo H; Li Y; Guan X; Chen Y; Wang Z; Yuan P; Wang J; Luo Y; Fan Y; Cai R; Li Q; Chen S; Zhang P; Li Q; Ma F; Xu B
Front Oncol; 2021; 11():670723. PubMed ID: 34046360
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and survival outcomes in patients with breast cancer and lung metastasis: a population-based study.
Xiao W; Zheng S; Liu P; Zou Y; Xie X; Yu P; Tang H; Xie X
Cancer Med; 2018 Mar; 7(3):922-930. PubMed ID: 29473333
[TBL] [Abstract][Full Text] [Related]
4. Risk and prognostic factors of breast cancer with liver metastases.
Ji L; Cheng L; Zhu X; Gao Y; Fan L; Wang Z
BMC Cancer; 2021 Mar; 21(1):238. PubMed ID: 33676449
[TBL] [Abstract][Full Text] [Related]
5. Incidence proportions and prognosis of breast cancer patients with bone metastases at initial diagnosis.
Gong Y; Zhang J; Ji P; Ling H; Hu X; Shao ZM
Cancer Med; 2018 Aug; 7(8):4156-4169. PubMed ID: 29984914
[TBL] [Abstract][Full Text] [Related]
6. Incidence, risk factors and survival of patients with brain metastases at initial metastatic breast cancer diagnosis in China.
Li Y; Li Q; Mo H; Guan X; Lin S; Wang Z; Chen Y; Zhang Y; Zhang D; Chen S; Cai R; Wang J; Luo Y; Fan Y; Yuan P; Zhang P; Li Q; Ma F; Xu B
Breast; 2021 Feb; 55():30-36. PubMed ID: 33310633
[TBL] [Abstract][Full Text] [Related]
7. Incidence and prognostic factors of patients with synchronous liver metastases upon initial diagnosis of breast cancer: a population-based study.
Zhao HY; Gong Y; Ye FG; Ling H; Hu X
Cancer Manag Res; 2018; 10():5937-5950. PubMed ID: 30538544
[TBL] [Abstract][Full Text] [Related]
8. Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer.
Inoue M; Nakagomi H; Nakada H; Furuya K; Ikegame K; Watanabe H; Omata M; Oyama T
Breast Cancer; 2017 Sep; 24(5):667-672. PubMed ID: 28108967
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer brain metastases at initial diagnosis.
Leone JP; Leone J; Zwenger AO; Iturbe J; Leone BA; Vallejo CT
Eur J Cancer; 2017 Mar; 74():17-25. PubMed ID: 28335884
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors and survival according to tumor subtype in newly diagnosed breast cancer with liver metastases: A competing risk analysis.
Chen QF; Huang T; Shen L; Wu P; Huang ZL; Li W
Mol Clin Oncol; 2019 Sep; 11(3):259-269. PubMed ID: 31396386
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
Li X; Zhang X; Liu J; Shen Y
BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
[TBL] [Abstract][Full Text] [Related]
12. Men and women show similar survival outcome in stage IV breast cancer.
Wu SG; Zhang WW; Liao XL; Sun JY; Li FY; Su JJ; He ZY
Breast; 2017 Aug; 34():115-121. PubMed ID: 28577471
[TBL] [Abstract][Full Text] [Related]
13. New insights into patterns of first metastatic sites influencing survival of patients with hormone receptor-positive, HER2-negative breast cancer: a multicenter study of 271 patients.
Yamamura J; Kamigaki S; Fujita J; Osato H; Manabe H; Tanaka Y; Shinzaki W; Hashimoto Y; Komoike Y
BMC Cancer; 2021 Apr; 21(1):476. PubMed ID: 33926418
[TBL] [Abstract][Full Text] [Related]
14. De novo metastasis in breast cancer: occurrence and overall survival stratified by molecular subtype.
Press DJ; Miller ME; Liederbach E; Yao K; Huo D
Clin Exp Metastasis; 2017 Dec; 34(8):457-465. PubMed ID: 29288366
[TBL] [Abstract][Full Text] [Related]
15. Features Associated With Long-Term Survival in Patients With Metastatic Breast Cancer.
Klar N; Rosenzweig M; Diergaarde B; Brufsky A
Clin Breast Cancer; 2019 Aug; 19(4):304-310. PubMed ID: 30827763
[TBL] [Abstract][Full Text] [Related]
16. Brain Metastases in Newly Diagnosed Breast Cancer: A Population-Based Study.
Martin AM; Cagney DN; Catalano PJ; Warren LE; Bellon JR; Punglia RS; Claus EB; Lee EQ; Wen PY; Haas-Kogan DA; Alexander BM; Lin NU; Aizer AA
JAMA Oncol; 2017 Aug; 3(8):1069-1077. PubMed ID: 28301662
[TBL] [Abstract][Full Text] [Related]
17. Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome.
Lobbezoo DJ; van Kampen RJ; Voogd AC; Dercksen MW; van den Berkmortel F; Smilde TJ; van de Wouw AJ; Peters FP; van Riel JM; Peters NA; de Boer M; Borm GF; Tjan-Heijnen VC
Breast Cancer Res Treat; 2013 Oct; 141(3):507-14. PubMed ID: 24104881
[TBL] [Abstract][Full Text] [Related]
18. Receptor conversion and survival in breast cancer liver metastases.
Sundén M; Norgren S; Lundqvist R; Andersson A; Sund M; Hemmingsson O
Breast Cancer Res; 2023 Sep; 25(1):105. PubMed ID: 37705026
[TBL] [Abstract][Full Text] [Related]
19. The effect of distant metastases sites on survival in de novo stage-IV breast cancer: A SEER database analysis.
Wu SG; Li H; Tang LY; Sun JY; Zhang WW; Li FY; Chen YX; He ZY
Tumour Biol; 2017 Jun; 39(6):1010428317705082. PubMed ID: 28653887
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological characteristics and prognosis of metaplastic breast cancer versus triple-negative invasive ductal carcinoma: a retrospective analysis.
Yang X; Tang T; Zhou T
World J Surg Oncol; 2023 Nov; 21(1):364. PubMed ID: 37996840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
